Australia
Neurizon's NUZ-001 Reduces Aggregation of Key ALS Disease Target TDP-43 in Preclinical Study
Highlights: * Positive preclinical results in human in vitro iPSC Motor Neuron models of Amyotrophic Lateral Sclerosis (ALS) * Neurizon's lead drug NUZ-001 and its major active metabolite significantly and dose-dependently prevented the aggregation of TAR DNA-binding protein 43 (TDP-43) by ~...
2024-11-19 20:30
789
Neurizon Therapeutics Receives Positive Opinion on Orphan Medicinal Product Designation for NUZ-001 in Europe
Highlights: * Notice of positive opinion received from the European Medicines Agency for Orphan Medicinal Product Designation for NUZ-001 in Amyotrophic Lateral Sclerosis * Orphan Designation offers 10 years of market exclusivity in Europe upon product approval, along with additional regulat...
2024-11-11 20:30
1003
Global Finals of the 17th Chinese Bridge--Chinese Proficiency Competition for Foreign Secondary School Students Successfully Held in Tianjin
TIANJIN, China, Oct. 30, 2024 /PRNewswire/ -- On the evening of October 28, the global finals and awarding ceremony for the 17th Chinese Bridge—Chinese Proficiency Competition for Foreign Secondary School Students and the 4th Chinese Bridge—Chinese Show for Foreign Primary School Students took pl...
2024-10-31 03:03
1610
$3M GRANT TO ACCELERATE DEVELOPMENT OF NEUROPLASTOGENS FOR SUBSTANCE USE DISORDER TREATMENT
CRC-P GRANT SECURED BY TESSARA THERAPEUTICS, PSYLO, AND THE UNIVERSITY OF SYDNEY
TO ADVANCE BRAIN-REWIRING TREATMENTS FOR ADDICTION
BOULDER, Colo. , Oct. 28, 2024 /PRNewswire/ -- Tessara Therapeutics
2024-10-29 02:00
1445
MicuRx Announces the Successful Completion of Phase 1 Clinical Trial of MRX-5 in Australia
SHANGHAI, Oct. 25, 2024 /PRNewswire/ -- Recently, Shanghai MicuRx Pharmaceutical Co., Ltd. ("MicuRx", 688373.SH) announced the successful completion of Phase I clinical trial of MRX-5 inAustralia, a self-developed oral antibacterial agent in development for the treatment of nontuberculous mycoba...
2024-10-25 19:29
1315
RateMyAgent Announces Strategic Acquisition of Curated Social, Bolstering Market Position and Expanding Offerings
MELBOURNE, Australia, Oct. 23, 2024 /PRNewswire/ -- Just six months after appointing a new CEO and rejuvenating its Board of Directors, RateMyAgent, a leading player in the real estate review and reputation management industry, is excited to announce that they have signed a binding agreement to a...
2024-10-23 23:00
2881
Doceree forms Strategic Partnership with The Ward Marketing Group to Strengthen Its Global Footprint; Expands into Australian Market
Expanding its reach from 22 markets to include Australia, Doceree partners with The Ward Marketing Group to enhance HCP-patient engagement in the region through innovative marketing solutions. SYDNEY, Oct. 23, 2024 /PRNewswire/ -- Doceree, the world's first global network of physician-only platf...
2024-10-23 19:05
1381
30,000 Marathon Enthusiasts Ignite the Beauty of Dalian with Their Run
DALIAN, China, Oct. 21, 2024 /PRNewswire/ -- At 7:30 on October 20th, the 34th Dalian Marathon kicked off, with 30,000 marathon enthusiasts successively dashing past the starting line. They crossed the city, running passionately in the cool weather, while being cheered on by enthusiastic citizens...
2024-10-21 21:21
2291
Universal Robots unveils its AI Accelerator, enabling a new wave of AI-powered cobot innovations
ODENSE, Denmark, Oct. 21, 2024 /PRNewswire/ -- Universal Robots, the Danish
collaborative robot (cobot) company, has today presented for the first time the
UR AI Accelerator
2024-10-21 15:00
1329
Copper-67 SAR-bisPSMA updates
SYDNEY, Oct. 16, 2024 /PRNewswire/ -- HIGHLIGHTS Cohort 4 - SECuRE Trial * The third participant of cohort 4 (multi-dose) of the SECuRE trial1 has now completed the Dose Limiting Toxicity (DLT) period after a second dose of 12GBq of67Cu-SAR-bisPSMA, following on from the announcement dated 1...
2024-10-16 21:03
2184
Getac to Demonstrate Edge-AI Capabilities through its X600 Rugged Mobile Workstation at IACP
News in brief: * Getac's Edge AI-based solution is designed for public safety agencies to quickly extract critical information from video footage and gain situational awareness during emergencies. * The basic solution provides edge computing work with the X600 rugged mobile workstation, whi...
2024-10-16 21:00
1489
The 2024 Ningbo Open Kicks Off
NINGBO, China, Oct. 16, 2024 /PRNewswire/ -- On October 14, the main event of the 2024 Ningbo Open officially commenced! After partnering with the Women's Tennis Association (WTA) for the first time last year, the Ningbo Open has been upgraded to a WTA 500 event this year, reflectingNingbo's incr...
2024-10-16 20:15
1449
PharmAust affirms corporate strategy with name change to Neurizon Therapeutics
MELBOURNE, Australia, Oct. 15, 2024 /PRNewswire/ -- Neurizon Therapeutics Limited (ASX: NUZ) ("Neurizon" or "the Company"), a clinical-stage biotech company dedicated to advancing treatments for neurodegenerative diseases, is pleased to announce it has officially changed its name from PharmAust L...
2024-10-16 04:14
1240
Delegation of International Communication Experts and Foreign Media Outlets Visit Zhongshan to Experience the City's Hustle and Bustle
BEIJING, Oct. 15, 2024 /PRNewswire/ -- Recently, the "World Comes to Zhongshan" delegation of international communication experts and foreign media outlets, organized by the CICG Academy of Translation and Interpretation, visited the most representative tourist attractions in Zhongshan, gaining a...
2024-10-15 23:44
2014
Cooper Investors Issues Open Letter to Board of Directors of Frontier Communications Opposing Acquisition by Verizon
Expresses Concern that $38.50 Offer Price Significantly Undervalues Frontier and Fails to Reflect Value of Anticipated Synergies Believes Frontier's Standalone Value is up to 62% Higher than Offer Price and Fair Transaction Value Would be up to 94% Higher than Offer Price Confident Frontier Rema...
2024-10-15 21:14
1465
Positive guidance from the U.S. FDA on 64Cu-SAR-bisPSMA Phase III trial in patients with recurrence of prostate cancer
Highlights * United States Food and Drug Administration (U.S. FDA) provided positive feedback on a pivotal Phase III trial for64Cu-SAR-bisPSMA diagnostic in prostate cancer patients with biochemical recurrence (BCR), AMPLIFY. * The positive results of the completed COBRA and PROPELLER trials,...
2024-10-14 21:02
1742
Delegation of International Communication Experts and Foreign Media Outlets Visits Emerging Industry Enterprises in Zhongshan, Guangdong Province
BEIJING, Oct. 10, 2024 /PRNewswire/ -- On October 9, 2024, the delegation of international communication experts and foreign media outlets, themed "The World Comes to Zhongshan" and organized by the CICG Academy of Translation and Interpretation, visited several representative enterprises in Zhon...
2024-10-11 00:53
1997
Delegation of International Communication Experts and Foreign Media Outlets Visits the Shenzhen-Zhongshan Link
BEIJING, Oct. 9, 2024 /PRNewswire/ -- On October 8, marking the 100-day anniversary of the opening of the Shenzhen-Zhongshan Link, a delegation of international communication experts and foreign media outlets, themed "The World Comes to Zhongshan," organized by the CICG Academy of Translation and...
2024-10-09 22:15
4770
Goodbye Darwin', Amerigo Vespucci bids farewell to Australia by ANSA in collaboration with Difesa Servizi
Thousands of visits on the training ship, next stop Singapore DARWIN, Australia, Oct. 7, 2024 /PRNewswire/ -- (ANSA) - (by correspondent Domenico Palesse) - Along the walkway that leads from the pier to the city, dozens of people wave Italian flags while on the horizon the silhouette of the Amer...
2024-10-08 06:37
1184
Saxony-Anhalt Presents Current and Future Investment Opportunities at Expo Real
MAGDEBURG, Germany, Oct. 4, 2024 /PRNewswire/ -- Innovative companies from high-tech industries looking to make history are warmly welcomed in Saxony-Anhalt. There is plenty of space for big plans here, as the Central German federal state offersEurope's largest investment opportunity with 700 he...
2024-10-04 19:09
5773
Week's Top Stories
Most Reposted
Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 304 media titles]
2024-11-20 13:29Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 297 media titles]
2024-11-20 16:30
Oxygen, HubSpot's leading solutions partner in Hong Kong & Greater China Expands to UAE
[Picked up by 296 media titles]
2024-11-15 15:25
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 282 media titles]
2024-11-20 09:00
Most Read
Oxygen, HubSpot's leading solutions partner in Hong Kong & Greater China Expands to UAE
2024-11-15 15:25
8669
How "small apples" march into "big industry" in Yan'an
2024-11-15 17:39
5220
Yingli Solar's Global Product Workshops Launched in Malaysia
2024-11-15 21:40
4613
